New drugs targeting calcitonin gene-related peptide for the management of migraines

Tana, Claudio; Cipollone, Francesco; Giamberardino, Maria Adele; Martelletti, Paolo

doi:10.1080/14728214.2023.2288334

Expert Opinion on Emerging Drugs

2023

DOI: 10.1080/14728214.2023.2288334

|View full text |Cite

New drugs targeting calcitonin gene-related peptide for the management of migraines

Claudio Tana,

Francesco Cipollone,

Maria Adele Giamberardino

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite1

Independent1

Authors

Journals

Cited by 2 publications

References 57 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Health equity, care access and quality in headache – part 1

Tana,

Raffaelli,

Souza

et al. 2024

J Headache Pain

Self Cite

View full text Add to dashboard Cite

Current definitions of migraine that are based mainly on clinical characteristics do not account for other patient’s features such as those related to an impaired quality of life, due to loss of social life and productivity, and the differences related to the geographical distribution of the disease and cultural misconceptions which tend to underestimate migraine as a psychosocial rather than neurobiological disorder.Global differences definition, care access, and health equity for headache disorders, especially migraine are reported in this paper from a collaborative group of the editorial board members of the Journal of Headache and Pain. Other components that affect patients with migraine, in addition to the impact promoted by the migraine symptoms such as stigma and social determinants, are also reported.

show abstract

Health equity, care access and quality in headache – part 1

Tana,

Raffaelli,

Souza

et al. 2024

J Headache Pain

Self Cite

View full text Add to dashboard Cite

show abstract

Reconceptualizing autonomic function testing in migraine: a systematic review and meta-analysis

Pavelić,

Zebenholzer,

Wöber

2024

J Headache Pain

View full text Add to dashboard Cite

Background Autonomic nervous system (ANS) testing has aided in our ability to evaluate autonomic dysfunction in migraine patients. We reviewed the literature in multiple databases which investigate ANS function in migraine patients and healthy subjects. Methods This systematic review and meta-analysis examined the respective deep breathing, Valsalva manoeuvre, orthostatic and isometric challenge results, using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Meta-analyses of Observational Studies in Epidemiology (MOOSE) statements. Results Seven articles met all inclusion criteria. Fixed-effects meta-analysis showed migraine patients (n = 424), collectively, had lower interictal autonomic test results compared with healthy controls (n = 268). In detail, this was true for the standardized mean difference (g) of deep breathing (g= -0.32; 95% confidence interval (CI) -0.48, -0.16), orthostatic challenge (g= -0.28; 95% CI -0.44, -0.13) and isometric challenge (g= -0.55; 95% CI -0.71, -0.39) and for the difference of means (MD) of the Valsalva ratio (MD = -0.17; 95% CI -0.23, -0.10). Conclusions Interictal ANS dysfunction can be identified in migraine patients when compared to healthy controls. These findings indicate the importance to evaluate ANS function in migraine patients - especially, as migraine-specific prophylactic therapies (such as anti-calcitonin gene-related peptide (CGRP) antibodies) may affect the function of the ANS.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

New drugs targeting calcitonin gene-related peptide for the management of migraines

Cited by 2 publications

References 57 publications

Health equity, care access and quality in headache – part 1

Health equity, care access and quality in headache – part 1

Reconceptualizing autonomic function testing in migraine: a systematic review and meta-analysis

Contact Info

Product

Resources

About